GAN LTD (GAN) Fundamental Analysis & Valuation

NASDAQ:GAN • BMG3728V1090

Current stock price

1.97 USD
+0.01 (+0.51%)
At close:
1.9601 USD
-0.01 (-0.5%)
After Hours:

This GAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GAN Profitability Analysis

1.1 Basic Checks

  • In the past year GAN has reported negative net income.
  • GAN had a positive operating cash flow in the past year.
  • GAN had negative earnings in each of the past 5 years.
  • GAN had negative operating cash flow in 4 of the past 5 years.
GAN Yearly Net Income VS EBIT VS OCF VS FCFGAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • GAN has a worse Return On Assets (-14.14%) than 87.31% of its industry peers.
Industry RankSector Rank
ROA -14.14%
ROE N/A
ROIC N/A
ROA(3y)-80.41%
ROA(5y)-52.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GAN Yearly ROA, ROE, ROICGAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • Looking at the Gross Margin, with a value of 68.73%, GAN belongs to the top of the industry, outperforming 82.09% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GAN has declined.
  • GAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y-1.7%
GAN Yearly Profit, Operating, Gross MarginsGAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. GAN Health Analysis

2.1 Basic Checks

  • GAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GAN has more shares outstanding than it did 1 year ago.
  • GAN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GAN has a worse debt to assets ratio.
GAN Yearly Shares OutstandingGAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GAN Yearly Total Debt VS Total AssetsGAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -3.56, we must say that GAN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of GAN (-3.56) is worse than 94.03% of its industry peers.
  • GAN has a debt to FCF ratio of 11.79. This is a negative value and a sign of low solvency as GAN would need 11.79 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 11.79, GAN is in line with its industry, outperforming 54.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.79
Altman-Z -3.56
ROIC/WACCN/A
WACC7.12%
GAN Yearly LT Debt VS Equity VS FCFGAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that GAN should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.57, GAN is doing good in the industry, outperforming 75.37% of the companies in the same industry.
  • A Quick Ratio of 1.57 indicates that GAN should not have too much problems paying its short term obligations.
  • GAN's Quick ratio of 1.57 is fine compared to the rest of the industry. GAN outperforms 76.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
GAN Yearly Current Assets VS Current LiabilitesGAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GAN Growth Analysis

3.1 Past

  • GAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.43%, which is quite impressive.
  • The Revenue has been growing slightly by 7.02% in the past year.
  • The Revenue has been growing by 35.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)7.02%
Revenue growth 3Y2.82%
Revenue growth 5Y35.1%
Sales Q2Q%-4.19%

3.2 Future

  • GAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
  • GAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.90% yearly.
EPS Next Y47.61%
EPS Next 2Y6.55%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue Next Year-4.82%
Revenue Next 2Y2.15%
Revenue Next 3Y3.9%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GAN Yearly Revenue VS EstimatesGAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
GAN Yearly EPS VS EstimatesGAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. GAN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GAN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GAN Price Earnings VS Forward Price EarningsGAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • 74.63% of the companies in the same industry are cheaper than GAN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GAN indicates a somewhat cheap valuation: GAN is cheaper than 69.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.44
EV/EBITDA 31.02
GAN Per share dataGAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • GAN's earnings are expected to grow with 13.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.55%
EPS Next 3Y13.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GAN Dividend Analysis

5.1 Amount

  • No dividends for GAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

GAN Fundamentals: All Metrics, Ratios and Statistics

GAN LTD

NASDAQ:GAN (5/23/2025, 8:18:27 PM)

After market: 1.9601 -0.01 (-0.5%)

1.97

+0.01 (+0.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-09
Earnings (Next)08-07
Inst Owners31.54%
Inst Owner Change0%
Ins Owners7.71%
Ins Owner Change0%
Market Cap91.53M
Revenue(TTM)133.71M
Net Income(TTM)-10.63M
Analysts46.67
Price Target2.01 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1219.36%
Min EPS beat(2)-2327.72%
Max EPS beat(2)-111%
EPS beat(4)2
Avg EPS beat(4)-556.24%
Min EPS beat(4)-2327.72%
Max EPS beat(4)177.66%
EPS beat(8)3
Avg EPS beat(8)-288.04%
EPS beat(12)5
Avg EPS beat(12)-466.6%
EPS beat(16)6
Avg EPS beat(16)-402.26%
Revenue beat(2)0
Avg Revenue beat(2)-21.32%
Min Revenue beat(2)-23.68%
Max Revenue beat(2)-18.97%
Revenue beat(4)2
Avg Revenue beat(4)-8.85%
Min Revenue beat(4)-23.68%
Max Revenue beat(4)5.93%
Revenue beat(8)3
Avg Revenue beat(8)-9.89%
Revenue beat(12)3
Avg Revenue beat(12)-8.37%
Revenue beat(16)5
Avg Revenue beat(16)-6.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54%
EPS NY rev (1m)0%
EPS NY rev (3m)-112.82%
Revenue NQ rev (1m)-6.59%
Revenue NQ rev (3m)-7.27%
Revenue NY rev (1m)-8.67%
Revenue NY rev (3m)-13.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.68
P/FCF 22.44
P/OCF 12.53
P/B N/A
P/tB N/A
EV/EBITDA 31.02
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.09
FCFY4.46%
OCF(TTM)0.16
OCFY7.98%
SpS2.88
BVpS-0.35
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.73%
FCFM 3.05%
ROA(3y)-80.41%
ROA(5y)-52.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y-1.7%
F-Score4
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.79
Debt/EBITDA 14.97
Cap/Depr 41.36%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion 227.42%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z -3.56
F-Score4
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)45.66%
Cap/Depr(5y)80.76%
Cap/Sales(3y)5.61%
Cap/Sales(5y)8.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y47.61%
EPS Next 2Y6.55%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue 1Y (TTM)7.02%
Revenue growth 3Y2.82%
Revenue growth 5Y35.1%
Sales Q2Q%-4.19%
Revenue Next Year-4.82%
Revenue Next 2Y2.15%
Revenue Next 3Y3.9%
Revenue Next 5YN/A
EBIT growth 1Y83.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1701.45%
EBIT Next 3Y226.63%
EBIT Next 5YN/A
FCF growth 1Y128.56%
FCF growth 3YN/A
FCF growth 5Y0.48%
OCF growth 1Y314.28%
OCF growth 3YN/A
OCF growth 5Y0.79%

GAN LTD / GAN Fundamental Analysis FAQ

What is the fundamental rating for GAN stock?

ChartMill assigns a fundamental rating of 2 / 10 to GAN.


What is the valuation status of GAN LTD (GAN) stock?

ChartMill assigns a valuation rating of 1 / 10 to GAN LTD (GAN). This can be considered as Overvalued.


What is the profitability of GAN stock?

GAN LTD (GAN) has a profitability rating of 1 / 10.


What is the financial health of GAN LTD (GAN) stock?

The financial health rating of GAN LTD (GAN) is 2 / 10.


What is the earnings growth outlook for GAN LTD?

The Earnings per Share (EPS) of GAN LTD (GAN) is expected to grow by 47.61% in the next year.